 | Myelodysplastic Syndromes: Pathobiology and Clinical Management DAVID P. STEENSMA is a Consultant and Associate Professor of Medicine and Oncology at Mayo Clinic, Rochester, Minnesota, USA. Originally from the New York City suburbs, he received his M.D. from the Pritzker School of Medicine at the University of Chicago, Chicago, Illinois, USA. Dr. Steensma completed his clinical training in internal medicine, hematology and medical oncology at Mayo Clinic, and research training at the Weatherall Institute of Molecular Medicine in Oxford, England. His laboratory efforts focus on the molecular genetics of MDS, and he is also currently conducting several clinical trials aimed at improving outcomes and quality of life for patients with myelodysplastic syndromes (MDS) and various forms of anemia. He is a member of the North Central Cancer Treatment Group, Mayo Clinic Cancer Research Consortium, and the Eastern Cooperative Oncology Group Leukemia Committee. |
